PB CPD Online e-learning site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2008) 32: 390-393. doi: 10.1192/pb.bp.107.019109
© 2008 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Tiangga, E.
Right arrow Articles by Dent, J. A.
PubMed
Right arrow Articles by Tiangga, E.
Right arrow Articles by Dent, J. A.

Vitamin D deficiency in psychiatric in-patients and treatment with daily supplements of calcium and ergocalciferol

Eleanor Tiangga, Specialist Trainee Year 3 and Asha Gowda, Specialist Trainee Year 3

John A. Dent, Consultant Psychiatrist

St Bernards Hospital, 2nd floor, Tony Hillis Wing, Southall, Middlesex UB13EU, email: john.dent{at}wlmht.nhs.uk

Declaration of interest

None.

AIMS AND METHOD

This study examines the prevalence of vitamin D deficiency in a group of male psychiatric in-patients and follows 16 of them prospectively during treatment with calcium and ergocalciferol tablets.

RESULTS

Of 17 male patients, 15 had vitamin D deficiency and two had borderline deficiency. Vitamin D deficiency was associated with Black and minority ethnic background. Improvement in vitamin D status was observed following replacement therapy.

CLINICAL IMPLICATIONS

Vitamin D deficiency may be widespread in the psychiatric population particularly in Black and minority ethnic but also in White European in-patients. Vitamin D level should be routinely monitored in psychiatric in-patients. For those with vitamin D deficiency, replacement therapy can be commenced with calcium and ergocalciferol tablets (containing 10 µg of ergocalciferol), which is safe and well tolerated. All psychiatric in-patients should have adequate exposure to sunlight and attention to diet to ensure that they receive their recommended daily allowance of vitamins and minerals.




eLetters:

Read all eLetters

Vitamin D deficiency in psychiatric inpatients
Rayin N Kulambil Padinjakara, et al.
PB Online, 9 Oct 2008 [Full text]
Vitamin D deficiency and mental illness
Vishelle Kamath, et al.
PB Online, 27 Oct 2008 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2008 The Royal College of Psychiatrists.